Nardoc
ActiveSummary
Nardoc has been active since 2012 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €214,201 and a net result of -€6,468. Equity remains stable across the filed fiscal years (±0.2% per year). Its solvency ranks better than 94% of 2939 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).
History
Acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
28-09
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema · 59 days late
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · full schema
2024
31-12
Financial
Weakest financial yearnet -€40,801
Net result drops to -€40,801, the lowest in the series; recovery starts the following year.
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Liquidity quadruplescurrent ratio 40.05
Current ratio from 8.95 to 40.05; short-term debt falls from €31,012 to €6,349.
28-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-08
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 31 days late
2021
30-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 30 days late
2020
29-08
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 29 days late
2019
31-12
Financial
Highest result since 2018net €37,686 ▲27.7%
Operating result €43,156, net result €37,686, both a record.
29-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
2018
29-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 60 days late
2017
31-10
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema · 92 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.